F1000Research · 2019 · 23 citations · 34 references
Life SciencesMicrobiologyPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyInnate ImmunityAntibacterial PharmacologyBacterial Pathogenesis In PlantsMedicinal PlantsAntimicrobial Use In AquacultureBacterial Disease PreventionHerbal ProphylaxisPseudomonas Aeruginosa Infection TreatmentPseudomonas Fluorescens
<ns4:p> <ns4:bold>Background:</ns4:bold> The combination of some plant extracts to prevent and treat bacterial infections is gaining momentum, because of effectiveness against certain bacteria. This study aims to describe the antibacterial and immunostimulant abilities of <ns4:italic>Boesenbergia pandurata</ns4:italic> (BP), <ns4:italic>Solanum ferox</ns4:italic> (SF) and <ns4:italic>Zingiber Zerumbet</ns4:italic> (ZZ) plant extracts to treat and prevent <ns4:italic>Aeromonas hydrophila</ns4:italic> and <ns4:italic>Pseudomonas fluorescens</ns4:italic> infection on Tilapia ( <ns4:italic>Oreochromis niloticus</ns4:italic> ). </ns4:p> <ns4:p> <ns4:bold>Methods:</ns4:bold> Tilapia (initial weight 15±2 g) were injected intramuscularly (0.1 ml/fish) with a combination of <ns4:italic>A. hydrophila</ns4:italic> and <ns4:italic>P. fluorescens</ns4:italic> at a density of 1×10 <ns4:sup>5</ns4:sup> CFU ml <ns4:sup>-1</ns4:sup> of each bacteria. Treatment trials were performed at day 7 post-injection with each combined extract, while the prevention trial was performed by including the combined extract into the commercial diet for six and seven days prior to injection. Various extract combinations were 60 mg SF extract/kg feed with 40 mg ZZ/kg feed (SF60/ZZ40), SF50/ZZ50, BP90/SF10, and BP50/SF50. Haemato-immunological parameters were performed for four weeks. </ns4:p> <ns4:p> <ns4:bold>Results:</ns4:bold> In prevention trials, tilapia fed SF50/ZZ50 showed a significant increase of white and red blood cells. Similarly, significantly increased haematocrit was found in tilapia fed SF50/ZZ50 in the treatment trial but not in the prevention trial. In both trials, haemoglobin of tilapia was not affected by any combined extracts but decreased the number of bacteria. Phagocytic index, respiratory burst, lysozyme activity and survival rate of fish fed combined extracts were found significantly higher than controls. The amount of pathogenic bacteria in fish fed combined extracts was lower than the control at week 4 ( <ns4:italic>P<0.05</ns4:italic> ). In both trials The percentage of survival rate and relative percent survival of tilapia fed SF 50/ZZ 50, showed the optimum results compared to the other combinations. </ns4:p> <ns4:p> <ns4:bold>Conclusions:</ns4:bold> The combined extract in feed, especially SF50/ZZ50 has a positive effect on the tilapia's innate immune system of tilapia to treat and prevent bacterial infections. </ns4:p>
34
Routine haematological methods for use with fish blood
P. C. Blaxhall, K. W. Daisley · Journal of Fish Biology · 1973 · 1.6K citations
Current research status of fish immunostimulants
Masahiro Sakai · Aquaculture · 1999 · 1.3K citations
Life Sciences, Immunology, Zoology +10